50 years ago, colorectal cancer was often found too late. Thanks to federally funded research & common screening tools (colonoscopies/stool tests), we've slashed mortality rates by 50%. Take action with us: brnw.ch/21wW5AL #SaveResearchStopCancer #ASCOAdvocacy

On #WCRD, we're excited to announce the inaugural cohort of the International Clinical Research Scholars (ICRS) Program in partnership with Aortic-Africa! Join us in celebrating their commitment: brnw.ch/21wW46w

🚨 #ASCOQLTY25 Registration Alert‼️ (before rates go up this Friday)! 🗣️ Engage in meaningful discussions 🤝 Build lasting relationships 🔋 Leave feeling energized & inspired ➡️ Join us in Chicago Oct 10-11, 2025 @ascocancer.bsky.social www.asco.org/quality/registration-hotels/registration-details

Today is #WorldCancerResearchDay. At ASCO, we support the advancement of cancer research through education, mentorship, funding research through @conquercancer.bsky.social Grants & Awards and so much more. Together, we can change lives! Learn more: brnw.ch/21wW3p8

In a new editorial for #ASCODailyNews, Drs. Jasmin Hundal & Neil Iyengar discuss the rise of obesity-related cancers in younger adults and the need to integrate metabolic interventions into cancer prevention and survivorship strategies: brnw.ch/21wW1m6

Advances in immunotherapy have led to a 5x increase in 5-year survival rates for metastatic melanoma. This incredible progress was driven in part by federally funded research. We can’t go back. Take action with us: brnw.ch/21wVZ8G #SaveResearchStopCancer #ASCOAdvocacy

Exciting news! We’ve launched ASCO Edge, an online oncology practice management educational series exclusively available to ASCO members. Get started today: brnw.ch/21wVVu3

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

There are 18 million cancer survivors in the U.S. That’s 6x more than there were 50 years ago, thanks to decades of progress driven in large part by federally funded research. We can’t go back. Take action with us: brnw.ch/21wVV2D #SaveResearchStopCancer #ASCOAdvocacy

🧬🎙️ Our classic paradigms of screening & referral fall apart in the new era of proliferating indications of germline #genetictesting in cancer. I discuss a program w/ Dr. Hoffman using non-genetics providers to increase access while maintaining quality. @ascocancer.bsky.social

New guideline alert for oncology professionals! 🚨 ASCO & ONS just dropped their "Management of Antineoplastic Extravasation" guideline. Get the latest on antidotes, thermal compresses, and surgical referrals for extravasation. Read it here: brnw.ch/21wVTFD

Earlier this week, ASCO, @astro-org.bsky.social & @socsurgonc.bsky.social released a guideline with new recommendations for postmastectomy RT for patients with #breastcancer. #ASCODailyNews has more, including interviews with members of the joint task force: brnw.ch/21wVTiX

New guidelines for PMRT are a game-changer! They provide a clear roadmap for oncologists who need radiation therapy, with a preference for moderate hypofractionation and DIBH for tissue sparing. Read the full article: brnw.ch/21wVRpN

Be part of the next gen of #MedEd leaders & cultivate a community w/ our Leadership Development Program: Education Scholars. The program offers leadership training & techniques to facilitate learning & problem solving. Apply by Nov 17: brnw.ch/21wVRbf

New draft protocol alert! 🚨 ASCO's "Treatment of Advanced #BiliaryTractCancer" is open for comments until September 24. Share your feedback: brnw.ch/21wVMBd

Thank you, ASCO member Dr. Chancellor Donald, for advocating for robust federal cancer research funding for NIH & NCI in the FY26 budget. Read his letter on NOLA.com: brnw.ch/21wVMmx

For decades, chemotherapy & radiation meant weeks in hospital enduring harsh side effects. Today's treatments, developed from fed funded research, offer better outcomes & quality of life. We can’t go back. Take action: brnw.ch/21wVLXR #SaveResearchStopCancer #ASCOAdvocacy

The draft guideline update, #immunotherapy and targeted therapy for advanced gastroesophageal cancer, is now available for open comment. Provide your feedback to us by September 24. #esocsm Learn more: brnw.ch/21wVG8d

Dr. Pedro Barata of University Hospitals Seidman Cancer Center and Dr. Rana McKay of University of San Diego discuss emerging treatment paradigms in RCC and UC on the latest episode of ASCO Education #BytheBook Podcast: brnw.ch/21wVFUe

LAST CHANCE! Apply for the IDEA program with special QI mentorship opportunity. #LMIC oncologists — don’t miss this opportunity: apply today: brnw.ch/21wVE8u

Missed the latest Grand Rounds webinar on the TAPUR Study? 🎓 No worries—you can now stream the full session and catch up on expert insights into precision oncology and targeted therapies. Watch now and stay informed: brnw.ch/21wVBdO

The @ascocancer.bsky.social #InternationalAffairsCommittee #2025-26. An absolute delight and pleasure working with these highly engaged professionals from across the world 🌎 and across oncology disciplines. #BestASCOCommittee

Chair-Elect @ryannipp.bsky.social, MPH, FASCO, attended @ascocancer.bsky.social Quality as a trainee, and the science, education, and community he found there has kept him coming back.   “For many of us, it is our favorite meeting of the year." #ascoQLTY25

There are 18 million US cancer survivors today, a 5x increase since 1971. Federal research funding has delivered for Americans in the form of extended lives & healthier futures. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVzeC

Investing in research today prevents suffering tomorrow & ensures our national scientific standing. We cannot turn away from millions counting on American ingenuity to live healthier lives. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVvP3

Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial. Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more: brnw.ch/21wVvcH

Showcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard. Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: brnw.ch/21wVrHY

Federal funding cuts jeopardize America's leadership in cancer innovation. Cuts slow progress, cost future discoveries, increase dependence on foreign treatments, & gamble with health of all. #ASCOAdvocacy #SaveResearchStopCancer Take action with us: brnw.ch/21wVrkG

Abstract titles for #ASCOQLTY25 are now live! Get a first look at the solution-oriented cancer research that will be presented at the symposium: asco.org/qcs-abstracts If you haven’t yet confirmed your attendance, registration is still open: brnw.ch/21wVpzR

Nice piece in @ascocancer.bsky.social Connection with perspectives from 2 early-career oncologists, one in community practice and the other in academia, on parts of oncology not covered during training @ivyrianomd.bsky.social & Ibrahim Azar connection.asco.org/do/eight-asp...

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS

50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs #SaveResearchStopCancer #ASCOAdvocacy Take action with us: brnw.ch/21wVh17

Congratulations to @realbowtiedoc.bsky.social and @mazietsangmd.bsky.social on this excellent editorial highlighting the future of performance status assessment in oncology 👏 Thank you for the kind shout-out; honored to see our work cited #JCOOP @ascocancer.bsky.social ascopubs.org/doi/10.1200/...

🎧 What if palliative care wasn’t just early, but precise? On the latest @ascocancer.bsky.social Daily News Podcast, Drs. #RamySedhom & @realbowtiedoc.bsky.social dive into precision palliative care - meeting patients’ real needs 👉 Listen now dailynews.ascopubs.org/do/podcast-p...

A new global guideline on #geriatricassessment is here! Get the details and see how it can impact patient care. Read more: brnw.ch/21wVfLW

There’s still time to apply for the IDEA program! Oncologists in #LMICs — get mentorship, ASCO Annual Meeting access, and a special opportunity to work with a QI mentor. Apply by: Sept 30th: brnw.ch/21wVeYz

⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)

America’s legacy of advances in cancer, powered by fed research funding, transformed care & saved countless lives. Our legacy is a light of hope for patients & families. We must not abandon it. #SaveResearchStopCancer #ASCOAdvocacy Take action with us: www.asco.org/get-involved...

We’re accepting comments on our draft living guideline Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations. Submit feedback to us by September 3: brnw.ch/21wV8b2

With almost 3,000 patients enrolled at 260 sites in the last 9 years, we are seeking a Scientific PI to keep the project moving forward and expanding. Interested or know anyone who may be? Learn more & apply: asco.org/TAPUR-PI

A heartfelt ‘thank you’ to the innovator and longtime leader of our #TAPUR Study, Dr. Richard Schilsky, who will transition into his new role as Founding Principal Investigator of TAPUR in 2026. We are grateful for his leadership and contributions over many, many years.

Early-career oncologists: Last call to apply for YIA and GO YIA funding! Don’t miss this deadline. Apply today: brnw.ch/21wV5FB

Read the full @wsj.com article in which our Chair of the Board and Past President Dr. Robin Zon is quoted, highlighting the "tremendous" advances in breast oncology: brnw.ch/21wV4rv

Join us at #GI26 to learn about the latest diagnostic and therapeutic strategies in GI cancers to transform your patient outcomes in a program planned by and featuring multidisciplinary experts. Register today: brnw.ch/21wV49s

Medicare #telehealth flexibilities will end Sept. 30 unless Congress acts. These flexibilities are important for pts w #cancer who need uninterrupted access to care. Join #ASCOAdvocacy in urging lawmakers to permanently extend them: brnw.ch/21wV2oM

The CDA supports early-career clinical investigators building independent research career in clinical oncology. U.S. & international applicants welcome. Applications due Oct 9: brnw.ch/21wV06y

ASCO works to shape health policy to improve #cancer treatment & pt access to care. What policies should we develop or update next? Let us know using our topic submission form: tinyurl.com/4k2sr4nk

Hear how the IDEA program shaped the careers of early-career oncologists in LMICs. Gain mentorship, networking, global collaboration and more. Special Quality Improvement (QI) mentorship opportunity available as well! Apply by September 30th: brnw.ch/21wUSSl

Dr. Hope Rugo of @cityofhope.bsky.social and Dr. Kamaria Lee of @mdanderson.bsky.social discuss novel approaches to mitigate financial toxicity for patients with breast cancer globally on the ASCO Education #BytheBook Podcast: brnw.ch/21wUQV6 #ASCOEdBook

If you’re interested in taking that next step toward leadership, a quick reminder that applications for our Leadership Development Program are open through September 22. Learn more & apply today: brnw.ch/21wUPkM